Treating mantle cell lymphoma earlier in the disease course

At the 20th Congress of the European Hematology Association (EHA), Marek Trněný, MD, PhD, of Charles University, Prague, Czech Republic, discusses the movement towards utilizing novel therapeutic agents earlier in the disease course of mantle cell lymphoma.

Share this video  
12th June 2015